PT-2017-15754 · Oracle+1 · Virtualbox+1

Publicado 2017-01-27 · Atualizado 2017-07-01 · CVE-2017-3290

Positive Technologies (AI Summary)

CVSS v3.1

7.9

Alta

Vetor base

AV:L/AC:L/PR:H/UI:N/S:C/C:N/I:H/A:H

Name of the Vulnerable Software and Affected Versions Oracle VM VirtualBox versions prior to 5.0.32 Oracle VM VirtualBox versions prior to 5.1.14

Description The issue allows a high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. Successful attacks can result in unauthorized creation, deletion, or modification access to critical data or all Oracle VM VirtualBox accessible data and unauthorized ability to cause a hang or frequently repeatable crash of Oracle VM VirtualBox.

Recommendations For versions prior to 5.0.32, update to version 5.0.32 or later. For versions prior to 5.1.14, update to version 5.1.14 or later.

Correção

Identificadores relacionados

CVE-2017-3290

MGASA-2017-0078

OPENSUSE-SU-2017_0332-1

OPENSUSE-SU-2017_0382-1

Produtos afetados

Virtualbox

Suse

Referências · 15

• https://osv.dev/vulnerability/UBUNTU-CVE-2017-3290 · Aviso do Fabricante
• http://oracle.com/ocom/groups/public/@otn/documents/webcontent/3432537.xml · Nota
• http://securitytracker.com/id/1037638 · Nota
• https://virtualbox.org/wiki/Changelog · Nota
• https://bugs.mageia.org/show_bug.cgi?id=20222 · Nota
• https://osv.dev/vulnerability/CVE-2017-3290 · Aviso do Fabricante
• https://osv.dev/vulnerability/MGASA-2017-0078 · Aviso do Fabricante
• https://cve.org/CVERecord?id=CVE-2017-3290 · Nota de Segurança
• https://nvd.nist.gov/vuln/detail/CVE-2017-3290 · Nota de Segurança
• https://advisories.mageia.org/MGASA-2017-0078.html · Nota de Segurança
• http://oracle.com/technetwork/security-advisory/cpujan2017-2881727.html#AppendixOVIR · Nota
• https://ubuntu.com/security/CVE-2017-3290 · Aviso do Fabricante
• https://security.gentoo.org/glsa/201702-08 · Aviso do Fabricante
• http://securityfocus.com/bid/95601 · Nota
• http://oracle.com/technetwork/security-advisory/cpujan2017-2881727.html · Aviso do Fabricante